Pharmaceuticals & Medical Devices
Featured news
AIM Releases its Position on the Critical Medicines Act: A Call for Transparent, Sustainable, and Inclusive Measures
The International Association of Mutual Benefit Societies (AIM) has published its position on the European Commission’s proposal for a Critical Medicines Act, representing the views of its members a......
ECL, BEUC and AIM Urge EU Member States to Prioritise Affordable Medicines in Pharma Package Negotiations
As EU governments engage in critical negotiations on the revision of the EU Pharmaceutical Package, the Association of European Cancer Leagues (ECL), the European Consumer Organisation (BEUC), and the......
AIM WELCOMES THE EU CRITICAL MEDICINES ACT AS A STEP TOWARDS EQUITABLE ACCESS AND SUPPLY CHAIN RESILIENCE
The International Association of Mutual Benefit Societies (AIM) welcomes the recent publication of the EU Critical Medicines Act as a crucial initiative to strengthen equitable access to medicines acr......
Other news
AIM Releases its Position on the Critical Medicines Act: A Call for Transparent, Sustainable, and Inclusive Measures
The International Association of Mutual Benefit Societies (AIM) has pu...
ECL, BEUC and AIM Urge EU Member States to Prioritise Affordable Medicines in Pharma Package Negotiations
As EU governments engage in critical negotiations on the revision of t...
AIM WELCOMES THE EU CRITICAL MEDICINES ACT AS A STEP TOWARDS EQUITABLE ACCESS AND SUPPLY CHAIN RESILIENCE
The International Association of Mutual Benefit Societies (AIM) welcom...
STATEMENT ON THE EUROPEAN COMMISSION CALL FOR EVIDENCE ON THE CRITICAL MEDICINES ACT
In response to the Commission’s public consultation on the Critical...
A significant hurdle cleared towards the improvement of public health – AIM reacts to the ENVI vote on the pharmaceutical package
AIM welcomes the agreement by the European Parliament’s Committee on...
Solidaris closes its petitions for fair drug prices with more than 50.000 signatures
On Monday 19 February, our member Solidaris closed its petition for fa...
Petra van Holst, CEO of Zorgverzekeraars Nederland (ZN) “Dutch insurers apply AIM’s fair pricing calculator by default when negotiating drug prices with companies”
High medicines prices are now a reality across the EU, leading to ineq...
Interview with Jean-Pascal Labille, Secretary General of Solidaris on fair drug prices: “Since 2015, drug spending has spiraled out of control”
Mr. Labille, can you tell us about changes in the affordability of med...
Jens Baas, Chairman of the Board of Techniker Krakenkasse on fair medicines prices : “Medicines are now the second highest spending item of the German public health system”
High medicines prices are now a reality in the EU, leading to inequali...